j.palacios
TL2 Moderator · Breda
Contributes reviews on supplier material. Based in Breda.
Joined 20 August 2025 · last posted 5d
83 posts, newest first. Showing up to 150.
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #97 · Nutrition & Training › Protein & intake · 23 Jul 2026 · 13 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake.
-
Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #2 · Practice › Administration · 18 Jul 2026 · 2 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #29 · Practice › Dosing & titration · 15 Jul 2026 · 24 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #45 · Practice › Interactions · 14 Jul 2026 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #23 · Compounds › Cagrilintide & amylin analogues · 12 Jul 2026 · 0 likes post #22 answers the question as asked. The question underneath it is different. Historical amylin analogues: pramlintide was the only long-acting amylin analogue…
-
Coming back to: Telehealth prescribing models in the US Replied, post #11 · Regional › North America · 10 Jul 2026 · 1 like Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA shortage list is substantially constrained. The landscape changed when supply normalised.…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #52 · Practice › Administration · 5 Jul 2026 · 29 likes Picking up post #49: that is the part I would want checked first. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #123 · Sourcing › Logistics · 4 Jul 2026 · 29 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #41 · Sourcing › Independent verification · 25 Jun 2026 · 17 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #58 · Compounds › Oral incretins · 25 Jun 2026 · 5 likes Coming back to post #56, because the follow-up matters more than the original answer. PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple…
-
Pooling trials with different estimands Replied, post #43 · Evidence › Meta-analyses · 23 Jun 2026 · 6 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: Programming during a large energy deficit Replied, post #39 · Nutrition & Training › Resistance training · 22 Jun 2026 · 7 likes On post #35 — agreed on the reasoning, with one qualification. Deload weeks: periodic weeks (every 4 to 8 weeks) with reduced volume and intensity can help with…
-
Conditions that change the calculus rather than forbidding it Replied, post #23 · Safety › Contraindications · 18 Jun 2026 · 11 likes I read post #21 twice before replying, because I had assumed the opposite. Severe renal impairment (eGFR
-
GLP-1 receptor distribution: central and peripheral Replied, post #69 · Pharmacology › Receptor biology · 14 Jun 2026 · 0 likes This follows post #66 rather than contradicting it. GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons (appetite…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #59 · Outcomes › Progress reports · 13 Jun 2026 · 3 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
Official shortage notices and what they authorise Replied, post #90 · Access › Shortages · 6 Jun 2026 · 24 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #21 · Analytics › Home & field testing · 14 May 2026 · 17 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Bioimpedance and hydration: why the number moves Replied, post #43 · Outcomes › Body composition · 11 May 2026 · 29 likes Coming back to post #41, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Request: show the solution author in the topic list — what changed since Replied, post #53 · Meta › Feature requests · 2 May 2026 · 8 likes Alternatives: if you have thought of a way the current site might already serve your need, mention it. It helps assess whether the feature is truly missing or just not…
-
Private prescribing in the UK: what is actually involved Replied, post #5 · Regional › UK & Ireland · 27 Apr 2026 · 20 likes Picking up post #2: that is the part I would want checked first. NHS access has been restricted by commissioning criteria, not by licensing. Specialist…
-
Reading a home test result without over-claiming Replied, post #18 · Analytics › Home & field testing · 20 Apr 2026 · 1 like Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
Sample handling between despatch and injection Replied, post #29 · Analytics › Method validation · 10 Apr 2026 · 17 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
List price versus negotiated price versus what you pay Started this topic · Access › Pricing · 6 Apr 2026 · 1 like On the subject in the title: List price versus negotiated price versus what you pay Working notes rather than a conclusion. Documenting an access outcome, dated,…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #81 · Practice › Interactions · 5 Apr 2026 · 9 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Reading a home test result without over-claiming Started this topic · Analytics › Home & field testing · 27 Mar 2026 · 1 like Reading a home test result without over-claiming — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I…
-
Preservatives: function, testing, and limits — one year on Replied, post #6 · Pharmacology › Formulation chemistry · 24 Mar 2026 · 15 likes I read post #4 twice before replying, because I had assumed the opposite. Buffers and pH: the pH of a solution is buffered to maintain stability. The buffer system…
-
Oral versus injected administration claims for BPC-157 Replied, post #25 · Compounds › Repair & healing peptides · 17 Mar 2026 · 9 likes I read post #23 twice before replying, because I had assumed the opposite. For anyone arriving from search engines: this subcategory discusses published preclinical…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #18 · Evidence › Trials · 3 Mar 2026 · 1 like This follows post #15 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Preprint servers and what screening they do Replied, post #68 · Evidence › Preprints · 25 Feb 2026 · 28 likes post #67 answers the question as asked. The question underneath it is different. Peer review as a filter: published papers have survived a review process that rejects…
-
Journal club: LEADER as the historical anchor Replied, post #38 · Evidence › Journal club · 22 Feb 2026 · 0 likes Worth separating two things that post #34 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #11 · Analytics › HPLC & UHPLC · 22 Feb 2026 · 0 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #60 · Analytics › Impurities & related substances · 18 Feb 2026 · 10 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Managing an unplanned gap in supply Replied, post #35 · Access › Shortages · 18 Feb 2026 · 11 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #5 · Evidence › Trials · 16 Feb 2026 · 0 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #49 · Clinical › Bloodwork · 11 Feb 2026 · 11 likes On post #45 — agreed on the reasoning, with one qualification. TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #35 · Evidence › Study critique · 8 Feb 2026 · 0 likes Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #64 · Regional › UK & Ireland · 13 Jan 2026 · 29 likes This follows post #61 rather than contradicting it. Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #46 · Practice › Storage & stability · 5 Jan 2026 · 20 likes post #45 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #10 · Practice › Storage & stability · 4 Jan 2026 · 29 likes Worth separating two things that post #6 runs together. Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #30 · Pharmacology › Receptor biology · 27 Dec 2025 · 1 like Species differences: rodent studies show the same compounds produce effects in rodents that predict human effects reasonably well for semaglutide and tirzepatide. The…
-
Tracking a preprint to publication: a worked example Replied, post #146 · Evidence › Preprints · 14 Dec 2025 · 16 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #18 · Practice › Side effects · 22 Nov 2025 · 0 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #46 · Compounds › Tirzepatide · 12 Nov 2025 · 26 likes This follows post #43 rather than contradicting it. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a…
-
Managing an unplanned gap in supply — what changed since Replied, post #112 · Access › Shortages · 10 Nov 2025 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #56 · Compounds › Tirzepatide · 21 Oct 2025 · 27 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #25 · Safety › Adverse events · 16 Oct 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reading an interaction checker output critically Replied, post #18 · Practice › Interactions · 8 Oct 2025 · 18 likes Picking up post #15: that is the part I would want checked first. Supplements and herbs: many have no established interaction. Some do. If you are taking something…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #103 · Compounds › Cagrilintide & amylin analogues · 5 Oct 2025 · 3 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
High-resolution MS on aggregates and what it can see Replied, post #64 · Analytics › Mass spectrometry · 10 Sep 2025 · 4 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
A comparison of home results against a laboratory result on the same vial Replied, post #34 · Analytics › Home & field testing · 8 Sep 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Hypertension improvement and when medication needs revisiting Replied, post #40 · Clinical › Comorbidities · 4 Sep 2025 · 26 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #33 · Evidence › Journal club · 31 Aug 2025 · 1 like PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #56 · Compounds › Retatrutide · 20 Aug 2025 · 5 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
-
System suitability injections: if they failed, the run did not happen Replied, post #24 · Analytics › HPLC & UHPLC · 19 Aug 2025 · 11 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #33 · Analytics › COA interpretation · 14 Aug 2025 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #19 · Evidence › Journal club · 14 Aug 2025 · 16 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
A ten-fold dose error caught before injection — one year on Replied, post #128 · Devices › Syringes & needles · 4 Aug 2025 · 19 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #20 · Compounds › Tirzepatide · 29 Jul 2025 · 0 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Canadian access and provincial variation — one year on Replied, post #30 · Regional › North America · 25 Jul 2025 · 3 likes Telehealth prescribing: widespread in the US and varying in quality. Models without a clinician reviewing measurements and history are not recommended by this community.
-
A field-by-field walk through a certificate of analysis Replied, post #77 · Analytics › COA interpretation · 16 Jul 2025 · 26 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Payment mechanics and the recovery options that do not exist — what changed since Replied, post #16 · Sourcing › Payments · 22 Jun 2025 · 17 likes Bank transfer and finality: once a bank transfer is sent, it is final. The money is gone. There is no recourse with the bank if the supplier disappears. That is why…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #14 · Sourcing › Vendor reports · 19 Jun 2025 · 20 likes This follows post #11 rather than contradicting it. Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity.…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #46 · Clinical › Comorbidities · 22 May 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: What other technical communities get right that we do not Replied, post #102 · Lounge › Off topic · 18 May 2025 · 16 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #31 · Practice › Reconstitution · 1 Apr 2025 · 3 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Transit times by route, from a logged dataset — the long version Replied, post #75 · Sourcing › Logistics · 27 Mar 2025 · 0 likes Worth separating two things that post #71 runs together. At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for…
-
Reading a chromatogram someone posted without axes Replied, post #14 · Analytics › HPLC & UHPLC · 24 Mar 2025 · 11 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #80 · Evidence › Journal club · 19 Mar 2025 · 0 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Charge states for a 4 kDa peptide, worked through Replied, post #144 · Analytics › Mass spectrometry · 18 Mar 2025 · 25 likes post #143 is right about the mechanism and I think understates the practical bit. Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #62 · Wellbeing › Mental health · 15 Mar 2025 · 0 likes Identity and self-image: for some people, weight and body size are central to identity. Large change to body size can affect identity. This is not pathological; it is…
-
Consistent declarations and why they matter more than clever ones Replied, post #101 · Sourcing › Logistics · 28 Feb 2025 · 0 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
-
Coming back to: Official shortage notices and what they authorise Replied, post #33 · Access › Shortages · 22 Feb 2025 · 9 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
-
SNAC and the mechanism of oral peptide absorption Replied, post #2 · Compounds › Oral incretins · 14 Feb 2025 · 1 like PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
-
Coming back to: Renal impairment: what the labelling says about dose Replied, post #34 · Clinical › Special populations · 3 Feb 2025 · 17 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #100 · Evidence › Journal club · 21 Jan 2025 · 1 like SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #116 · Access › Insurance & coverage · 11 Jan 2025 · 33 likes This follows post #113 rather than contradicting it. Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a…
-
What changed in 2026, by region Replied, post #21 · Access › International · 14 Dec 2024 · 0 likes This follows post #18 rather than contradicting it. Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #61 · Clinical › Comorbidities · 19 Oct 2024 · 29 likes Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
-
About the Protein & intake category Replied, post #9 · Nutrition & Training › Protein & intake · 23 Sep 2024 · 0 likes Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of body weight. Individual requirements vary but that range is a…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #54 · Clinical › Prescriber conversations · 10 Sep 2024 · 13 likes What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and records of any adverse effects you have experienced with other…
-
Correlation in a self-tracked dataset: what it can support Replied, post #137 · Research Methods › Statistics · 25 Aug 2024 · 2 likes Multiplicity and multiple comparisons: if you test many hypotheses, the chance of finding a false positive by random chance increases. That is why pre-specifying the…
-
Chronic kidney disease and the FLOW result Replied, post #20 · Clinical › Comorbidities · 16 Aug 2024 · 0 likes This follows post #17 rather than contradicting it. Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision…
-
Journal club: FLOW and the renal composite, component by component Replied, post #28 · Evidence › Journal club · 11 Jul 2024 · 28 likes Coming back to post #26, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…